Novartis AG is 43.3x more valuable than Spyre Therapeutics, Inc. by market capitalization ($282.64 B vs $6.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SYRE | NVS |
|---|---|---|
| Market cap | $6.52 B | $282.64 B |
| US-listed rank | #1201 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$155.20M | - |
| SEC filings | 762 | 947 |
Novartis AG is 43.3x more valuable than Spyre Therapeutics, Inc. by market capitalization ($282.64 B vs $6.52 B).
Full pages: Spyre Therapeutics, Inc. and Novartis AG, or browse the full rankings.